SG1906

· Hangzhou Sumgen Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SG1906, covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: SG1906 for CLDN18.2-Positive Solid Tumors [Phase 1]